SYRE R&D Expenses
Spyre Therapeutics Inc · R&D Expenses
SYRE R&D Expenses
Latest reported$215.80Mperiod ending
SYRE TTM R&D Expenses ($6.83M → $215.80M)
TTM R&D Expenses
High-resolution chart · PNG
SYRE r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 215,799,000 | |
| 190,441,000 | |
| 171,653,000 | |
| 177,497,000 | |
| 176,994,000 | |
| 169,485,000 | |
| 162,790,000 | |
| 145,990,000 | |
| 125,906,000 | |
| 110,656,000 | |
| 89,504,000 | |
| 70,073,000 | |
| 57,390,000 | |
| 55,377,000 | |
| 58,579,000 | |
| 61,110,000 | |
| 63,986,000 | |
| 62,192,000 | |
| 57,069,000 | |
| 56,043,000 | |
| 53,641,000 | |
| 56,931,000 | |
| 59,638,000 | |
| 61,448,000 | |
| 66,836,000 | |
| 64,773,000 | |
| 64,600,000 | |
| 58,832,000 | |
| 49,922,000 | |
| 44,238,000 | |
| 36,719,000 | |
| 30,712,000 | |
| 28,022,000 | |
| 24,735,000 | |
| 22,814,000 | |
| 21,764,000 | |
| 20,910,000 | |
| 19,495,000 | |
| 18,142,000 | |
| 17,367,000 | |
| 15,111,000 | |
| 13,427,000 | |
| 11,453,000 | |
| 10,040,000 | |
| 9,398,000 | |
| 7,919,000 | |
| 6,830,000 |